<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="112684">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01982266</url>
  </required_header>
  <id_info>
    <org_study_id>EP052</org_study_id>
    <nct_id>NCT01982266</nct_id>
  </id_info>
  <brief_title>A Prospective, Multicenter, Single Arm Feasibility Study of the Safety and Performance of GRADION™ Hip Total Cartilage Replacement (TCR)™ in the Treatment of Degenerative Joint Disease of the Hip</brief_title>
  <official_title>A Prospective, Multicenter, Single Arm Feasibility Study of the Safety and Performance of GRADION™ Hip Total Cartilage Replacement (TCR)™ in the Treatment of Degenerative Joint Disease of the Hip</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biomimedica, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biomimedica, Inc</source>
  <oversight_info>
    <authority>Netherlands: Dutch Health Care Inspectorate</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multicenter, single arm feasibility study of the safety and
      performance of the GRADION™ Hip Total Cartilage Replacement (TCR)™  in patients who require
      cartilage replacement.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Degenerative Joint Disease of the Hip</condition>
  <arm_group>
    <arm_group_label>GRADION™ Hip Total Cartilage Replacement (TCR)™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GRADION™ Hip Total Cartilage Replacement (TCR)™</intervention_name>
    <arm_group_label>GRADION™ Hip Total Cartilage Replacement (TCR)™</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary hip surgery for Noninflammatory Degenerative Joint Disease (NIDJD) such as
             osteo/degenerative arthritis, and is indicated for cartilage replacement

          -  Skeletally mature or at least 18 years of age and has normal anatomy

          -  Patient signs the Informed Consent form

          -  Failed medical management

          -  There will be size limitations on patients also - available size range is 46mm-54mm.

        Exclusion Criteria:

          -  Allergic to polyether urethane, sodium polyacrylate, bone cement or any of its
             components

          -  Previous fusion, acute femoral neck fracture and/or above knee amputation

          -  Revision of any previous hip procedure

          -  Slipped capital femoral epiphysis (SCFE)

          -  Rheumatoid arthritis

          -  AVN
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rijnstate Arnhem</name>
      <address>
        <city>Arnhem</city>
        <zip>6815</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JLC van Susante, Dr.</last_name>
      <phone>088-0058888</phone>
    </contact>
    <investigator>
      <last_name>JLC van Susante, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 6, 2013</lastchanged_date>
  <firstreceived_date>November 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
